Over-representation of PPARγ sequence variants in sporadic cases of glioblastoma multiforme:: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population

被引:31
作者
Zhou, XP
Smith, WM
Gimm, O
Mueller, E
Gao, X
Sarraf, P
Prior, TW
Plass, C
von Deimling, A
Black, PM
Yates, AJ
Eng, C
机构
[1] Ohio State Univ, Clin Canc Genet Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol,Dept Cell Biol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[6] Boston Childrens Hosp, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[8] Univ Berlin, Charite Hosp, Dept Neuropathol, Berlin, Germany
关键词
peroxisome proliferator activated receptors; sequence variants; tumour suppressor;
D O I
10.1136/jmg.37.6.410
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
PPAR gamma, the gamma isoform of a family of peroxisome proliferator activated receptors, plays a key role in adipocyte differentiation. Recently, its broad expression in multiple tissues and several epithelial cancers has been shown. Further, somatic loss of function mutations in PPAR gamma have been found in primary colorectal carcinomas. We sought to determine if somatic high penetrance mutations in this gene might also play a role in glioblastoma multiforme (GBM). We also examined this gene to determine if common low penetrance polymorphic alleles might lend low level susceptibility to GEM in the general population. No somatic high penetrance mutations were detected in 96 sporadic GBMs. However, polymorphic alleles at codons 12 and 449 were significantly over-represented among the 27 unrelated American patients with sporadic GBM compared to 80 race matched controls. While nine (33%) were heterozygous for the P12A variant, c.34C/G (cytosine to guanine change at nucleotide 34), 12 (15%) controls were heterozygous for P12A (p<0.05). Similarly, 13 of 26 (50%) glioblastoma patients compared to 10 of 80 (12%) normal controls were found to have the heterozygous H449H polymorphism (p<0.001). The over-representation of H449H in glioblastoma patients was confirmed with a second validation set of American patients. When both American series were combined, polymorphic H449H was over-represented among cases versus controls (p<0.001) and there was a similar trend (p=0.07) for P12A. The precise mechanism for this association is unknown but these PPAR gamma polymorphisms may be acting ill a low penetrance predisposing manner. However, these associations were not found in a German population, possibly arguing that if variants are in linkage disequilibrium with a third locus, then this effect is relatively new, after the settlement of the American colonies.
引用
收藏
页码:410 / 414
页数:5
相关论文
共 23 条
[1]   Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells [J].
Brockman, JA ;
Gupta, RA ;
DuBois, RN .
GASTROENTEROLOGY, 1998, 115 (05) :1049-1055
[2]  
Cullingford TE, 1998, J NEUROCHEM, V70, P1366
[3]   PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies [J].
Dahia, PLM ;
Aguiar, RCT ;
Alberta, J ;
Kum, JB ;
Caron, S ;
Sill, H ;
Marsh, DJ ;
Ritz, J ;
Freedman, A ;
Stiles, C ;
Eng, C .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :185-193
[4]   Linkage disequilibrium mapping in isolated populations: The example of Finland revisited [J].
De La Chapelle, A ;
Wright, FA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12416-12423
[5]   A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity [J].
Deeb, SS ;
Fajas, L ;
Nemoto, M ;
Pihlajamäki, J ;
Mykkänen, L ;
Kuusisto, J ;
Laakso, M ;
Fujimoto, W ;
Auwerx, J .
NATURE GENETICS, 1998, 20 (03) :284-287
[6]   The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers [J].
DuBois, RN ;
Gupta, R ;
Brockman, J ;
Reddy, BS ;
Krakow, SL ;
Lazar, MA .
CARCINOGENESIS, 1998, 19 (01) :49-53
[7]   Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2 [J].
Elbrecht, A ;
Chen, YL ;
Cullinan, CA ;
Hayes, N ;
Leibowitz, MD ;
Moller, DE ;
Berger, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) :431-437
[8]   15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA [J].
FORMAN, BM ;
TONTONOZ, P ;
CHEN, J ;
BRUN, RP ;
SPIEGELMAN, BM ;
EVANS, RM .
CELL, 1995, 83 (05) :803-812
[9]   Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation [J].
Gimm, O ;
Neuberg, DS ;
Marsh, DJ ;
Dahia, PLM ;
Cuong, HV ;
Raue, F ;
Hinze, R ;
Dralle, H ;
Eng, C .
ONCOGENE, 1999, 18 (06) :1369-1373
[10]  
Inskip PD, 1995, EPIDEMIOL REV, V17, P382